Reportedly, MAT1A−/− mice can spontaneously develop steatosis, exhibiting reduced SOD activity and heightened lipid peroxidation, thereby accelerating the progression of NAFLD to NASH (Robinson et al., 2023). This evidence concerns the gene MAT1A and metabolic dysfunction-associated steatotic liver disease.